vs
Axon Enterprise(AXON)与Healthpeak Properties(DOC)财务数据对比。点击上方公司名可切换其他公司
Axon Enterprise的季度营收约是Healthpeak Properties的1.1倍($796.7M vs $719.4M),Healthpeak Properties净利率更高(73.2% vs 0.3%,领先72.8%),Axon Enterprise同比增速更快(38.9% vs 3.1%),Healthpeak Properties自由现金流更多($357.0M vs $155.4M),过去两年Axon Enterprise的营收复合增速更高(31.5% vs 8.9%)
Axon Enterprise是总部位于美国亚利桑那州斯科茨代尔的企业,面向军队、执法部门及民用市场开发各类武器装备与相关技术产品,业务覆盖公共安全、国防及民用消费等多个领域,为不同用户群体提供适配的产品解决方案。
Healthpeak Properties是美国医疗地产领域的房地产投资信托基金,核心投资范畴覆盖老年住宅、生命科学相关物业及医疗办公楼三类资产。公司2007年于马里兰州组建,总部设在科罗拉多州丹佛市,在尔湾、纳什维尔、旧金山均设有办事处,截至2019年12月31日共持有617处物业的权益。
AXON vs DOC — 直观对比
营收规模更大
AXON
是对方的1.1倍
$719.4M
营收增速更快
AXON
高出35.9%
3.1%
净利率更高
DOC
高出72.8%
0.3%
自由现金流更多
DOC
多$201.6M
$155.4M
两年增速更快
AXON
近两年复合增速
8.9%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $796.7M | $719.4M |
| 净利润 | $2.7M | $114.0M |
| 毛利率 | 57.9% | — |
| 营业利润率 | -6.3% | 17.4% |
| 净利率 | 0.3% | 73.2% |
| 营收同比 | 38.9% | 3.1% |
| 净利润同比 | -98.0% | 2406.4% |
| 每股收益(稀释后) | $0.02 | $0.16 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
AXON
DOC
| Q4 25 | $796.7M | $719.4M | ||
| Q3 25 | $710.6M | $705.9M | ||
| Q2 25 | $668.5M | $694.3M | ||
| Q1 25 | $603.6M | $702.9M | ||
| Q4 24 | $573.4M | $698.0M | ||
| Q3 24 | $544.3M | $700.4M | ||
| Q2 24 | $504.1M | $695.5M | ||
| Q1 24 | $460.7M | $606.6M |
净利润
AXON
DOC
| Q4 25 | $2.7M | $114.0M | ||
| Q3 25 | $-2.2M | $-117.1M | ||
| Q2 25 | $36.1M | $31.7M | ||
| Q1 25 | $88.0M | $42.8M | ||
| Q4 24 | $136.0M | $4.5M | ||
| Q3 24 | $67.0M | $85.9M | ||
| Q2 24 | $40.8M | $146.0M | ||
| Q1 24 | $133.2M | $6.7M |
毛利率
AXON
DOC
| Q4 25 | 57.9% | — | ||
| Q3 25 | 60.1% | 58.6% | ||
| Q2 25 | 60.4% | 60.2% | ||
| Q1 25 | 60.6% | 61.1% | ||
| Q4 24 | 60.5% | 60.3% | ||
| Q3 24 | 60.8% | 60.0% | ||
| Q2 24 | 60.3% | 60.6% | ||
| Q1 24 | 56.4% | 59.8% |
营业利润率
AXON
DOC
| Q4 25 | -6.3% | 17.4% | ||
| Q3 25 | -0.3% | 9.2% | ||
| Q2 25 | -0.2% | 5.7% | ||
| Q1 25 | -1.5% | 7.7% | ||
| Q4 24 | -2.6% | -2.2% | ||
| Q3 24 | 4.4% | 14.1% | ||
| Q2 24 | 6.5% | 22.3% | ||
| Q1 24 | 3.5% | 3.7% |
净利率
AXON
DOC
| Q4 25 | 0.3% | 73.2% | ||
| Q3 25 | -0.3% | -16.6% | ||
| Q2 25 | 5.4% | 4.6% | ||
| Q1 25 | 14.6% | 6.1% | ||
| Q4 24 | 23.7% | 0.7% | ||
| Q3 24 | 12.3% | 12.3% | ||
| Q2 24 | 8.1% | 21.0% | ||
| Q1 24 | 28.9% | 1.1% |
每股收益(稀释后)
AXON
DOC
| Q4 25 | $0.02 | $0.16 | ||
| Q3 25 | $-0.03 | $-0.17 | ||
| Q2 25 | $0.44 | $0.05 | ||
| Q1 25 | $1.08 | $0.06 | ||
| Q4 24 | $1.68 | $0.02 | ||
| Q3 24 | $0.86 | $0.12 | ||
| Q2 24 | $0.53 | $0.21 | ||
| Q1 24 | $1.73 | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $1.7B | $467.5M |
| 总债务越低越好 | $1.8B | $9.8B |
| 股东权益账面价值 | $3.2B | $7.5B |
| 总资产 | $7.0B | $20.3B |
| 负债/权益比越低杠杆越低 | 0.56× | 1.31× |
8季度趋势,按日历期对齐
现金及短期投资
AXON
DOC
| Q4 25 | $1.7B | $467.5M | ||
| Q3 25 | $2.4B | $91.0M | ||
| Q2 25 | $2.1B | $89.4M | ||
| Q1 25 | $2.2B | $70.6M | ||
| Q4 24 | $788.1M | $119.8M | ||
| Q3 24 | $1.0B | $180.4M | ||
| Q2 24 | $968.9M | $106.9M | ||
| Q1 24 | $964.1M | $101.8M |
总债务
AXON
DOC
| Q4 25 | $1.8B | $9.8B | ||
| Q3 25 | $2.0B | $9.1B | ||
| Q2 25 | $2.0B | $9.0B | ||
| Q1 25 | $2.0B | $8.9B | ||
| Q4 24 | $680.3M | $8.7B | ||
| Q3 24 | — | $8.6B | ||
| Q2 24 | — | $8.6B | ||
| Q1 24 | — | $8.8B |
股东权益
AXON
DOC
| Q4 25 | $3.2B | $7.5B | ||
| Q3 25 | $3.0B | $7.6B | ||
| Q2 25 | $2.7B | $7.9B | ||
| Q1 25 | $2.6B | $8.2B | ||
| Q4 24 | $2.3B | $8.4B | ||
| Q3 24 | $2.1B | $8.6B | ||
| Q2 24 | $1.9B | $8.8B | ||
| Q1 24 | $1.8B | $8.9B |
总资产
AXON
DOC
| Q4 25 | $7.0B | $20.3B | ||
| Q3 25 | $6.7B | $19.6B | ||
| Q2 25 | $6.2B | $19.8B | ||
| Q1 25 | $6.1B | $19.8B | ||
| Q4 24 | $4.5B | $19.9B | ||
| Q3 24 | $4.0B | $20.0B | ||
| Q2 24 | $3.7B | $20.2B | ||
| Q1 24 | $3.6B | $20.5B |
负债/权益比
AXON
DOC
| Q4 25 | 0.56× | 1.31× | ||
| Q3 25 | 0.66× | 1.20× | ||
| Q2 25 | 0.73× | 1.14× | ||
| Q1 25 | 0.79× | 1.08× | ||
| Q4 24 | 0.29× | 1.04× | ||
| Q3 24 | — | 1.00× | ||
| Q2 24 | — | 0.98× | ||
| Q1 24 | — | 0.99× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $217.2M | $1.3B |
| 自由现金流经营现金流 - 资本支出 | $155.4M | $357.0M |
| 自由现金流率自由现金流/营收 | 19.5% | 49.6% |
| 资本支出强度资本支出/营收 | 7.8% | 124.4% |
| 现金转化率经营现金流/净利润 | 79.14× | 10.99× |
| 过去12个月自由现金流最近4个季度 | $75.1M | — |
8季度趋势,按日历期对齐
经营现金流
AXON
DOC
| Q4 25 | $217.2M | $1.3B | ||
| Q3 25 | $60.0M | $315.0M | ||
| Q2 25 | $-91.7M | $363.5M | ||
| Q1 25 | $25.8M | $279.4M | ||
| Q4 24 | $250.2M | $1.1B | ||
| Q3 24 | $91.3M | $318.2M | ||
| Q2 24 | $82.8M | $316.2M | ||
| Q1 24 | $-15.9M | $152.6M |
自由现金流
AXON
DOC
| Q4 25 | $155.4M | $357.0M | ||
| Q3 25 | $33.4M | — | ||
| Q2 25 | $-114.7M | — | ||
| Q1 25 | $932.0K | — | ||
| Q4 24 | $225.4M | $333.7M | ||
| Q3 24 | $64.8M | — | ||
| Q2 24 | $71.4M | — | ||
| Q1 24 | $-32.1M | — |
自由现金流率
AXON
DOC
| Q4 25 | 19.5% | 49.6% | ||
| Q3 25 | 4.7% | — | ||
| Q2 25 | -17.2% | — | ||
| Q1 25 | 0.2% | — | ||
| Q4 24 | 39.3% | 47.8% | ||
| Q3 24 | 11.9% | — | ||
| Q2 24 | 14.2% | — | ||
| Q1 24 | -7.0% | — |
资本支出强度
AXON
DOC
| Q4 25 | 7.8% | 124.4% | ||
| Q3 25 | 3.7% | — | ||
| Q2 25 | 3.4% | — | ||
| Q1 25 | 4.1% | — | ||
| Q4 24 | 4.3% | 105.6% | ||
| Q3 24 | 4.9% | — | ||
| Q2 24 | 2.2% | — | ||
| Q1 24 | 3.5% | — |
现金转化率
AXON
DOC
| Q4 25 | 79.14× | 10.99× | ||
| Q3 25 | — | — | ||
| Q2 25 | -2.54× | 11.48× | ||
| Q1 25 | 0.29× | 6.52× | ||
| Q4 24 | 1.84× | 235.43× | ||
| Q3 24 | 1.36× | 3.71× | ||
| Q2 24 | 2.03× | 2.17× | ||
| Q1 24 | -0.12× | 22.85× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AXON
| Software And Sensors Segment | $342.5M | 43% |
| TASER Devices Professional | $264.2M | 33% |
| Personal Sensors | $109.1M | 14% |
| Platform Solutions | $80.9M | 10% |
DOC
暂无分部数据